HYBRID EVENT: Join us in person in Barcelona, Spain or attend virtually from anywhere.

10th Edition of World Congress on Infectious Diseases

June 25-27, 2026 | Barcelona, Spain

June 25 -27, 2026 | Barcelona, Spain

Infection 2026

Speaker at Infectious Diseases Conferences - Ranjan Ramasamy
Keynote Presentation (In-Person)
Ranjan Ramasamy, ID-FISH Technology, United States

The changing state of protective immunity to COVID-19 in the global population during the six and a half years since COVID-19’s origin in 2019 is analysed in the context of the (i) circulation of SARS-CoV-2 in the population, (ii) widespread use of different types of C [....] » Read More

Speaker at Infection Conferences - Yazdan Mirzanejad
Keynote Presentation (In-Person)
Yazdan Mirzanejad, University of British Columbia, Canada

Extensively drug-resistant (XDR) bacterial infections represent a growing global crisis with profound impacts on morbidity, mortality, and health system sustainability. These pathogens, resistant to nearly all available antibiotics, are rapidly outpacing our therapeutic options a [....] » Read More

Speaker at Infection Conferences - Vincenzo Pennone
Keynote Presentation (In-Person)
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy

Orthopedic implant-associated infections, frequently caused by Staphylococcus species, remain a major clinical concern due to biofilm formation and the growing threat of antimicrobial resistance. Antimicrobial peptides (AMPs), derived from the human cathelicidin LL-37, represent [....] » Read More

Speaker at Infectious Diseases Conferences - Ranjan Ramasamy
Oral Presentation (In-Person)
Ranjan Ramasamy, ID-FISH Technology, United States

Detection of specific antibodies is important for diagnosing Lyme disease (LD). Until recently, this required two separate tests termed the standard two-tier tests (STTTs). The development of one-step immunoblot (IB) tests for detecting IgG and IgM antibodies in patient sera, ter [....] » Read More

Speaker at Infectious Diseases Conference - Christabel Emaeyak James
Oral Presentation (In-Person)
Christabel Emaeyak James, University of Glasgow, United Kingdom

The novel Coronavirus Disease 2019 (covid-19), which emerged in Wuhan, China is a highly infectious disease caused by (SARS-CoV-2) and has significantly affected public health and socio-economic well-being worldwide. Its transmission highlights the potentially important role of t [....] » Read More

Speaker at Infection Conferences - Nicole Freiberger
Oral Presentation (In-Person)
Nicole Freiberger, INBIRS-CONICET, Argentina

Brucellosis, caused by Brucella abortus (Ba), remains a neglected zoonosis with significant human morbidity, often associated with chronic inflammatory manifestations. While traditionally regarded as passive reservoirs of energy, adipocytes are now recognized as immunometabolic [....] » Read More

Speaker at Infection Conference - Elmira Rastyamovna Samitova
Oral Presentation (In-Person)
Elmira Rastyamovna Samitova, Sechenov First Moscow State Medical University, Russian Federation

Pneumocystosis, caused by Pneumocystis jirovecii, is an opportunistic infection that is well-studied and occurs in immunocompromised patients, particularly those with HIV infection, as well as in patients with systemic rheumatic diseases and organ transplants who are receiving im [....] » Read More

Speaker at Infection Conference - Chihang Chang
Oral Presentation (In-Person)
Chihang Chang, Kang Chiao International School Linkou Campus, Taiwan

The aim of this study is to investigate whether mycorrhizal fungi infect plant species such as Vigna angularis, Vigna radiata, and Allium tuberosum to promote growth, or whether they instead contribute to disease. Existing literature highlights the complexity of these interaction [....] » Read More

Speaker at Infectious Diseases Conference - Yucheng Lin
Oral Presentation (In-Person)
Yucheng Lin, Kang Chiao International School Linkou Campus, Taiwan

The aim of this study is to investigate whether mycorrhizal fungi infect plant species such as Vigna angularis, Vigna radiata, and Allium tuberosum to promote growth, or whether they instead contribute to disease. Existing literature highlights the complexity of these interaction [....] » Read More

Speaker at Infectious Diseases Conference - Hade Ramos
Oral Presentation (In-Person)
Hade Ramos, Pontificia Universidad Catolica de Chile, Chile

Introduction: The Andes virus (ANDV), a rodent-borne Orthohantavirus, causes hantavirus cardiopulmonary syndrome (HCPS) in Chile and Argentina. Its genome comprises three RNA segments: large (L), medium (M), and small (S). The S segment encodes the nucleocapsid (N) and the non-st [....] » Read More

Speaker at Infectious Diseases Conference - Hatice Ceylan
Oral Presentation (In-Person)
Hatice Ceylan, Burdur Mehmet Akif Ersoy University, Turkey

Background: Inflammatory Bowel Disease, comprising Crohn's disease and ulcerative colitis, presents as a chronic, relapsing-remitting inflammatory condition of the gastrointestinal tract, necessitating a multidisciplinary approach to optimize patient outcomes (Schiavoni et al [....] » Read More

Speaker at Infectious Diseases Conference - Xueli Zheng
Oral Presentation (In-Person)
Xueli Zheng, Southern Medical University, China

Aedes albopictus (Ae. albopictus), an important vector of dengue virus (DENV), is distributed worldwide. Identifying host proteins involved in flavivirus replication in Ae. albopictus and determining their natural antiviral mechanisms are critical to control virus transmission. R [....] » Read More

Speaker at Infectious Diseases Conference - Ambati Mrudula Srinivasulu
Oral Presentation (In-Person)
Ambati Mrudula Srinivasulu, Yoda Diagnostics, India

Background: Non-tuberculous mycobacteria (NTM) are increasingly recognized as clinically significant pathogens that can mimic Mycobacterium tuberculosis (MTB) in both clinical presentation and laboratory features. Because of intrinsic drug resistance and overlapping morpholo [....] » Read More

Speaker at Infectious Diseases Conferences - Arnab Roy
Oral Presentation (In-Person)
Arnab Roy, NIPER Hyderabad, India

Background: The persistence of mycobacterium tuberculosis (Mtb) during chemotherapy is a major obstacle to shortening tuberculosis (TB) treatment. A key survival mechanism is the bacterium's metabolic redundancy, specifically the presence of two terminal oxidases for respirat [....] » Read More

Speaker at Infectious Diseases Conference - Barsha Mohanty
Oral Presentation (In-Person)
Barsha Mohanty, CrisprBits Private Limited, India

Transboundary animal diseases like Foot-and-Mouth Disease Virus (FMDV) and Lumpy Skin Disease Virus (LSDV) mostly in Cattles are significant threats to livestock health, food security, and rural livelihoods in India. Their rapid spread across species and environments highlights t [....] » Read More

Speaker at Infection Conference - Samuel Ayo
Oral Presentation (In-Person)
Samuel Ayo, Chong Hua Hospital Fuente Cebu, Philippines

Background: Creutzfeldt-Jakob disease (CJD) is an exceedingly rare, fatal, and rapidly progressive neurodegenerative disorder caused by misfolded prion proteins. In the Philippines, CJD is underrecognized and underreported due to limited access to diagnostic modalities and the ab [....] » Read More

Speaker at Infection Conferences - Ray John M Salud
Oral Presentation (In-Person)
Ray John M Salud, Rizal Medical Center, Philippines

Background:Schistosomiasis, a neglected tropical disease, remains endemic in certain regions of the Philippines. This case highlights the importance of considering neuroschistosomiasis in the differential diagnosis of pediatric patients presenting with unexplained neurological sy [....] » Read More

Speaker at Infection Conference - Alexis Torres Rodriguez
Oral Presentation (In-Person)
Alexis Torres Rodriguez, NewYork-Presbyterian Queens Hospital, United States

Background: Brain abscess complicated by ventriculitis is a rare and life-threatening central nervous system (CNS) infection associated with high morbidity and mortality. While common pathogens include streptococci and anaerobic oral flora, Capnocytophaga species are uncommon cau [....] » Read More

Speaker at Infectious Diseases Conference - Thomas Repantis
Oral Presentation (In-Person)
Thomas Repantis, General Hospital Agios Andreas, Greece

Objectives: Septic arthritis is a potentially devastating complication of intra-articular injections, typically caused by Staphylococcus aureus or β-hemolytic streptococci. Infections due to viridans streptococci are exceedingly rare. Among them, Streptococcus sanguinis, an [....] » Read More

Speaker at Infectious Diseases Conference - Thomas Repantis
Oral Presentation (In-Person)
Thomas Repantis, General Hospital Agios Andreas, Greece

Objectives: Deep neck infections in previously irradiated tissues are rare but potentially devastating complications. Impaired vascularity, radiation-induced necrosis, and mucosal fragility predispose these patients to severe infections even after minor mucosal interventions. We [....] » Read More

Speaker at Infectious Diseases Conference - Dulce Gregorio Talavera
Oral Presentation (In-Person)
Dulce Gregorio Talavera, East Avenue Medical Center, Philippines

Streptococcus pyogenes meningitis is a rare entity, accounting for less than 1% of bacterial meningitis cases, with fewer than thirty cases reported in the past 25 years. It typically affects young children and older adults. In contrast, anti-N-methyl-D-aspartate receptor (NMDAR) [....] » Read More

Speaker at Infection Conferences - Ermira Muco
Oral Presentation (In-Person)
Ermira Muco, Mother Theresa University Hospital Center, Albania

Introduction: Legionellosis is an infectious pathology caused by bacteria of the genus Legionella. L. Pneumophilia was recognized as the cause of the disease in 1976. Water reservoirs are its transmitting agents. There are risk factors and predisposing conditions. Travel is a ser [....] » Read More

Speaker at Infectious Diseases Conference - Paulo Arroyo
Oral Presentation (In-Person)
Paulo Arroyo, George Eliot Hospita, United Kingdom

Objectives: Although several studies have shown that the application of antimicrobial stewardship (AMS) has a positive impact on reduction of antimicrobial resistance and therefore the clinical outcomes of patients, most of the studies were conducted some years ago, and there hav [....] » Read More

Speaker at Infectious Diseases Conference - Himanshu Gul Mirani
Oral Presentation (In-Person)
Himanshu Gul Mirani, Midland Metropolitan University Hospital, United Kingdom

Background: The diastolic shock index (DSI), calculated as heart rate divided by diastolic blood pressure, has emerging utility as a marker of vasodilatory shock and progression to septic shock in the emergency department. While pre-hospital shock index thresholds are recognised [....] » Read More

Speaker at Infectious Diseases Conference - Abhishek Kandikatla
Oral Presentation (In-Person)
Abhishek Kandikatla, SRM University, India

Biofilms are structured multicellular bacterial communities embedded in a self-produced extracellular matrix that can adhere to any biotic or abiotic surface. Biofilms associated infections, occurring in wounds, dental plaques, urinary tract and its persistence on medical devices [....] » Read More

Speaker at Infection Conferences - Neada Hoxha
Oral Presentation (In-Person)
Neada Hoxha, Regional Hospital of Diber, Albania

Introduction: Intravenous drug use (IVDU) is a growing global health concern associated with severe infections and comorbidities. Among these, spondylodiscitis has been increasingly reported across Europe and is now observed in Albania.Data from the Institute of Public Health (IH [....] » Read More

Speaker at Infection Conference - Daniel S. Bednarik
Oral Presentation (In-Person)
Daniel S. Bednarik, Semmelweis University, Hungary

Introduction: Clostridioides difficile infection (CDI) is one of the most common and severe causes of healthcare-associated diarrhea and is associated with substantial morbidity and mortality. Although CDI has traditionally posed a major clinical challenge in adult healthcare set [....] » Read More

Speaker at Infection Conferences - Qian Wang
Oral Presentation (In-Person)
Qian Wang, Texas A&M University College of Dentistry, United States

Deadly infectious diseases such as the medieval Black Death (plague) and 20th-century Ebola have caused catastrophic loss of human life and generated great fear in the past and in contemporary human populations. Infectious disease epidemics persist as a threat and certainly will [....] » Read More

Speaker at Infection Conference - Jong Hoon Kim
Oral Presentation (In-Person)
Jong Hoon Kim, International Vaccine Institute, Korea, Republic of

Constrained global oral cholera vaccine (OCV) supplies force difficult trade-offs between pre-emptive and reactive deployment in sub-Saharan Africa. To address this, we developed an analytical and simulation framework to optimize OCV allocation to minimize costs that account for [....] » Read More

Speaker at Infection Conferences - Abhinav Iyer
Oral Presentation (In-Person)
Abhinav Iyer, Dougherty Valley High School, United States

Nipah virus (NiV) is a highly pathogenic zoonotic paramyxovirus emerging in South and Southeast Asia. With mortality rates ranging from 40–70%, it is classified by the World Health Organization as a priority pathogen. Despite its major clinical impact, the regulatory potent [....] » Read More

Speaker at Infectious Diseases Conference - Camila Amormino Corsini
Oral Presentation (In-Person)
Camila Amormino Corsini, Oswaldo Cruz Foundation (Fiocruz Minas), Brazil

The immune response induced by SARS-CoV-2 vaccination in children and adolescents is not yet well defined regarding the intensity and duration of protective immunity in the medium and long term, which may indicate the need for booster doses and support public health decisions. Gi [....] » Read More

Speaker at Infection Conferences - Amanda Fox
Oral Presentation (In-Person)
Amanda Fox, Animal Research Initiative, United States

The spread of Highly Pathogenic Avian Influenza (HPAI) has recently expanded to unprecedented proportions. Its existence in livestock has been well documented with the primary animals of concern being chickens, ducks, turkeys, game birds, bovine, swine, sheep, mink, and foxes. Wi [....] » Read More

Speaker at Infection Conference - Luke Perera
Oral Presentation (In-Person)
Luke Perera, The Francis Crick Institute, United Kingdom

The viral fusion protein hemagglutinin (HA) is the predominant influenza surface glycoprotein and mediates engagement with and entry into host cells. Influenza A virus HAs are categorised into two broad and immunologically distinct phylogenetic groups. Group 2 HA subtypes include [....] » Read More

Speaker at Infection Conference - Sasha Leibholz
Poster Presentation (In-Person)
Sasha Leibholz, New York Presbyterian Columbia/Cornell, United States

An outbreak of Legionnaires’ disease began in New York City in July 2025. In this abstract we present a series of three severe cases of Legionella pneumonia seen in an urban academic emergency department: Case 1: A 71-year-old male with a history of hypertension, hy [....] » Read More

Speaker at Infectious Diseases Conference - Lauren Gruffi
Poster Presentation (In-Person)
Lauren Gruffi, New York Presbyterian Columbia/Cornell, United States

An outbreak of Legionnaires’ disease began in New York City in July 2025. In this abstract we present a series of three severe cases of Legionella pneumonia seen in an urban academic emergency department: Case 1: A 71-year-old male with a history of hypertension, hy [....] » Read More

Speaker at Infection Conference - Terri Menser
Poster Presentation (In-Person)
Terri Menser, Mayo Clinic, United States

Mayo Clinic Florida (MCF) was one of the early adopters of Epic’s 2.0 sepsis prediction tool nationwide. Beginning in early 2024, we launched the inpatient model, which included the implementation of an EHR integrated timer and checklist in July. These tools were deployed t [....] » Read More

Speaker at Infection Conference - Anam Azhar
Poster Presentation (In-Person)
Anam Azhar, Texas Health Resources, United States

We present the case of a 46-year-old male with well-controlled HIV infection on antiretroviral therapy who presented with a four-day history of fever, malaise, and jaundice. The patient, a pilot with recent travel to the United Kingdom and prior travel throughout North America, C [....] » Read More

Speaker at Infection Conference - Taylor Hermann
Poster Presentation (In-Person)
Taylor Hermann, University of South Florida, United States

Sporotrichosis is a subacute to chronic fungal infection caused by Sporothrix species, typically presenting with cutaneous or lymphocutaneous disease. Although traditionally associated with Latin America, zoonotic and environmental transmission has become increasingly recognize [....] » Read More

Speaker at Infectious Diseases Conference - Kesava Manikanta Achuta
Poster Presentation (In-Person)
Kesava Manikanta Achuta, Garden City Hospital, United States

Introduction: Infective endocarditis (IE) is a life-threatening condition with mortality approaching 30% with highly variable presentation. Although fever and cardiac murmurs are classic, their absence does not exclude IE. Among persons who inject drugs, right-sided IE is common [....] » Read More

Speaker at Infectious Diseases Conference - Maria Soura
Poster Presentation (In-Person)
Maria Soura, National and Kapodistrian University of Athens, Greece

Background: Pneumocystis jirovecii pneumonia (PJP) is a rare but serious opportunistic infection affecting immunocompromised individuals. Although Pneumocystis organisms may colonize healthy lungs, they can cause severe pneumonia in patients with impaired immunity, particula [....] » Read More

Speaker at Infection Conference - Luiz Filippe Simao Soares
Poster Presentation (In-Person)
Luiz Filippe Simao Soares, Federal University of Espírito Santo (UFES), Brazil

Background: Gestational toxoplasmosis, caused by the protozoan Toxoplasma gondii, is an infection that generates significant concern due to the risks associated with vertical transmission from mother to fetus, which occurs due to the parasite's ability to cross the placental [....] » Read More

Speaker at Infection Conference - Lucas Granja Cotrik
Poster Presentation (In-Person)
Lucas Granja Cotrik, University Veiga de Almeida, Brazil

Introduction: The genetic diversity of Trypanosoma cruzi, classified into different DTUs, has a major influence on the pathogenic mechanisms of Chagas disease. This variability accounts for differences in the expression of virulence factors such as trans-sialidases and mucins, af [....] » Read More

Speaker at Infection Conference - Yaira Eloisa Mendoza Montijo
Poster Presentation (In-Person)
Yaira Eloisa Mendoza Montijo, Autonomous University of Baja California, Mexico

Background: Opportunistic infections of the central nervous system (CNS) and retina are severe complications of advanced HIV/AIDS. However, their simultaneous presentation as the initial manifestation of AIDS is uncommon. The diagnostic challenge increases when the early cli [....] » Read More

Speaker at Infection Conferences - Devin Edjohn Michael Aballe
Poster Presentation (In-Person)
Devin Edjohn Michael Aballe, Vicente Sotto Memorial Medical Center Department of Internal Medicine, Philippines

Introduction: Catheter-related bloodstream infection (CRBSI) remains a major cause of morbidity and mortality among hemodialysis (HD) patients worldwide. In low- and middle-income settings, limited vascular-access options and prolonged catheter use heighten infection risk. Local [....] » Read More

Speaker at Infectious Diseases Conferences - Carmela Bianca Villacete
Poster Presentation (In-Person)
Carmela Bianca Villacete, St Luke's Medical Center - Quezon City, Philippines

Background: Immune Reconstitution Inflammatory Syndrome (IRIS) is a severe and potentially fatal inflammatory condition that can occur in severely immunocompromised patients, such as those with HIV, after initiating antiretroviral therapy (ART). The syndrome is triggered by [....] » Read More

Speaker at Infectious Diseases Conference - Cinderella Gerna
Poster Presentation (In-Person)
Cinderella Gerna, Dennis Molintas District Hospital, Philippines

Introduction: Central venous catheters (CVCs) are utilized as access for hemodialysis (HD) in emergency settings in Baguio General Hospital and Medical Center (BGHMC). CVCs remain the primary vascular access of chronic kidney disease (CKD) patients undergoing hemodialysis until [....] » Read More

Speaker at Infectious Diseases Conference - Sharrah Mae Tan
Poster Presentation (In-Person)
Sharrah Mae Tan, Chong Hua Hospital Fuente Cebu, Philippines

Background: Syphilis, caused by Treponema pallidum, is a multisystemic sexually transmitted infection recognized as a “great imitator.” Ocular syphilis, a manifestation of neurosyphilis, can occur at any stage and affect nearly all ocular structures presenting wi [....] » Read More

Speaker at Infectious Diseases Conference - Abhipsha Anuranjana
Poster Presentation (In-Person)
Abhipsha Anuranjana, Christian Medical College, India

Background: Systemic fungal infections cause significant morbidity and mortality in children. Antifungal resistance is a matter of concern, as choice of antifungal therapy for empirical and therapeutic purposes is guided by existing sensitivity patterns among Candida isolates. [....] » Read More

Speaker at Infectious Diseases Conference - Eliana Guedes Stehling
Poster Presentation (In-Person)
Eliana Guedes Stehling, University of Sao Paulo, Brazil

Antimicrobial resistance is a pressing global issue with significant implications for human health. The presence of human bacterial pathogens resistant to last-line treatments in ready-to-eat vegetables is particularly concerning, as it compromises food safety and poses a serious [....] » Read More

Speaker at Infectious Diseases Conference - Haneen I Eldos
Poster Presentation (In-Person)
Haneen I Eldos, Weill Cornell Medicine, Qatar

Background: Vector-borne diseases (VBDs) are increasingly recognized in Qatar, where mosquito-borne diseases have been reported more frequently in recent years. Qatar’s arid climate, with occasional rain, high humidity, and mild winters, creates windows suitable for mosquit [....] » Read More

Speaker at Infectious Diseases Conference - Lily Zheng
Poster Presentation (In-Person)
Lily Zheng, Rutgers Robert Wood Johnson Medical School, United States

Introduction: Extraintestinal manifestations of Clostridioides difficile infection (CDI) are rare, occurring in <1% of reported CDI cases. Risk factors include intestinal barrier disruption, previous hospitalization, advanced age (>65 years), and use of broad-spec [....] » Read More

Speaker at Infectious Diseases Conferences - Claudia Ferreira
Keynote Presentation (In-Person)
Claudia Ferreira, Sorbonne University, France

Bioterrorism is defined as “the intentional release or threat of release of biologic agents—viruses, bacteria, fungi, or their toxins—to cause disease or death in humans, animals, or crops.” Bioterrorism remains a significant and evolving threat to public [....] » Read More

Speaker at Infectious Diseases Conferences - Pedro Plans Rubio
Keynote Presentation (In-Person)
Pedro Plans Rubio, College of Physicians of Barcelona, Spain

The Immunization Agenda 2030 (IA2030) proposed by the 73rd World Health Assembly in 2020 committed to eliminating measles in at least five of the six WHO regions by 2030. Mean percentages of vaccination coverage with two, one and zero doses of measles vaccine in WHO regions in 20 [....] » Read More

Speaker at Infection Conferences - Ayana Isobe
Oral Presentation (In-Person)
Ayana Isobe, Emory University, United States

Background: Japan’s remote island communities face overlapping structural challenges, including rapid population aging, shortages of healthcare professionals, and limited medical resources, making the establishment of sustainable healthcare delivery systems an urgent priori [....] » Read More

Speaker at Infection Conferences - Salome Chika Igbokwe
Oral Presentation (In-Person)
Salome Chika Igbokwe, University of Saskatchewan, Canada

Background: Despite national progress towards the elimination of new infections, Tuberculosis (TB) remains a significant public health concern in Northern Saskatchewan (NS), Canada, disproportionately affecting Indigenous populations. The transmission dynamics and genetic strains [....] » Read More

Speaker at Infectious Diseases Conferences - Anna Fairweather
Oral Presentation (In-Person)
Anna Fairweather, University of Oxford, United Kingdom

Background: Deployment of effective vaccination against the various SARS-CoV-2 variants was crucial for controlling the spread of COVID-19. These retrospective modelling analyses evaluated the impact of the expanded adolescent COVID-19 vaccination in England at two different [....] » Read More

Speaker at Infectious Diseases Conference - Sai Yan Pyay Aung
Oral Presentation (In-Person)
Sai Yan Pyay Aung, Nanyang Technological University, Singapore

Co-infection studies indicate that primary influenza infection promotes pneumococcal virulence by causing capillary leakage of nutrients into the lower respiratory tract. This study investigates whether limiting the availability or uptake of auxotrophic B-vitamins can mitigate th [....] » Read More

Speaker at Infectious Diseases Conference - Renata Zorgetti Manganaro de Oliveira
Oral Presentation (In-Person)
Renata Zorgetti Manganaro de Oliveira, Base Hospital of São José do Rio Preto Medical School, Brazil

Introduction/Background: Toxoplasmosis of the central nervous system (CNS) ranks third among the most prevalent opportunistic infections defining AIDS in Brazil, with the brain being the most frequently affected site. Toxoplasma gondii myelitis is considered rare, even in immunos [....] » Read More

Speaker at Infectious Diseases Conference - Renata Zorgetti Manganaro de Oliveira
Oral Presentation (In-Person)
Renata Zorgetti Manganaro de Oliveira, Base Hospital of São José do Rio Preto Medical School, Brazil

Introduction: Invasive fungal infection caused by fungi of the Mucorales order is particularly associated with states of immunocompromise and clinical conditions characterized by hyperglycemia and acidosis. During the SARS-CoV-2 pandemic, an increased prevalence of hyperglyc [....] » Read More

Speaker at Infectious Diseases Conference - Fernanda De Blas Lopez
Oral Presentation (In-Person)
Fernanda De Blas Lopez, National Autonomous University of Mexico, Mexico

The COVID-19 pandemic exposed significant gaps in the clinical, ethical, and legal frameworks guiding healthcare professionals during epidemiological crises. In Mexico, while numerous guidelines and protocols were rapidly issued, ranging from clinical treatment recommendations to [....] » Read More

Speaker at Infection Conferences - Ali Hassan Gillani
Oral Presentation (In-Person)
Ali Hassan Gillani, Xi'an Jiaotong University, China

Background: Pakistan ranks 6th globally in antibiotic consumption, with patients frequently obtaining medications directly from community pharmacies. Our objective was to evaluate the medicine distribution behaviors of pharmacies for assumed and confirmed tuberculosis utilizing t [....] » Read More

Speaker at Infection Conferences - Ali Hassan Gillani
Oral Presentation (In-Person)
Ali Hassan Gillani, Xi'an Jiaotong University, China

Background: Pakistan is a high-burden country for tuberculosis patients, and medicines and fluoroquinolones hinder diagnosis. The available literature largely uses knowledge surveys and prescription or medical record analysis to assess healthcare practitioners' knowledge [....] » Read More

Speaker at Infectious Diseases Conference - Moiz Ahmed Khan
Oral Presentation (In-Person)
Moiz Ahmed Khan, Tabba Heart Institute, Pakistan

Introduction: Three patients who underwent angioplasty procedure at a cardiac tertiary care hospital between 29th December 2024 to 30th January 2025, developed high-grade fever with chills within 12 hours of the procedure. Blood culture from these patients yielded growth of pan-s [....] » Read More

Speaker at Infectious Diseases Conference - Brooke Skinner
Oral Presentation (In-Person)
Brooke Skinner, Brown University, United States

Plasmodium falciparum malaria infects 300-500 million individuals and accounts for over 600,000 deaths each year with the majority of deaths occurring in children under 5 years of age living in sub-Saharan Africa. In the past several years, morbidity and mortality due to&nbs [....] » Read More

Speaker at Infectious Diseases Conference - Amadu Dele Ohinoyi
Oral Presentation (In-Person)
Amadu Dele Ohinoyi, University of Ilorin Teaching Hospital, Nigeria

Background: Rotavirus remains a leading cause of severe childhood diarrhoea, contributing significantly to under-five morbidity and mortality worldwide. In August 2022, Nigeria introduced the rotavirus vaccine into its national immunization program. Continuous surveillance of cir [....] » Read More

Speaker at Infection Conference - Suraj Chandrabhan Singh
Oral Presentation (In-Person)
Suraj Chandrabhan Singh, Indian Institute of Technology Palakkad, India

Kawasaki Disease (KD) and Multisystem Inflammatory Syndrome in Children (MIS-C) share overlapping clinical features but differ markedly in severity and cardiac outcomes. Both conditions are characterized by systemic hyperinflammation, yet the cellular and metabolic mechanisms dri [....] » Read More

Speaker at Infectious Diseases Conference - Brahmchetna Bedi
Oral Presentation (In-Person)
Brahmchetna Bedi, Emory University, United States

Introduction: Sex differences have been observed in both the incidence and symptom burden of long COVID (LC), with women demonstrating a higher incidence than men (8.5% vs. 5.2%) and greater symptom burden (4.4% vs. 2.3%). Menopause is marked by declining estrogen levels, increas [....] » Read More

Speaker at Infectious Diseases Conference - Jay Bhargav
Oral Presentation (In-Person)
Jay Bhargav, Somerset Foundation Trust, United Kingdom

Background: Optimising models of care for hepatitis B treatment delivery is an important component of global hepatitis elimination strategies. However, centralised dispensing may increase travel and financial burden for patients, particularly in rural populations. Methods: A r [....] » Read More

Speaker at Infectious Diseases Conferences - Sinisa Skocibusic
Oral Presentation (In-Person)
Sinisa Skocibusic, Institute for Public Health of the Federation of Bosnia and Herzegovina, Bosnia and Herzegowina

Suboptimal immunization coverage remains a major public health concern in middle-income countries, particularly in decentralized health systems. Recent measles outbreaks in the Federation of Bosnia and Herzegovina (FBiH) highlight critical gaps in service delivery and continuity [....] » Read More

Speaker at Infection Conferences - Panayiota Christodoulou
Oral Presentation (In-Person)
Panayiota Christodoulou, Evangelismos General Hospital of Athens, Greece

A 71-year-old man  was admitted to our Department due to hematuria. From his medical history he reported  multiple ischemic strokes in the setting of atrial fibrillation, a pacemaker due to complete atrioventricular block and diabetes mellitus on insulin. From the cl [....] » Read More

Speaker at Infection Conference - Laura Camila Caceres Delgado
Oral Presentation (In-Person)
Laura Camila Caceres Delgado, Universidad Industrial de Santander, Colombia

Introduction: Pediatric urinary tract infections (UTIs) represent an important reservoir of antimicrobial- resistant pathogens, predominantly Escherichia coli, with limited regional data on susceptibility patterns and factors associated with resistance. Antimicrobial resistance [....] » Read More

Speaker at Infectious Diseases Conference - Jalees A Nasir
Oral Presentation (In-Person)
Jalees A Nasir, McMaster University, Canada

Sequencing technologies implemented across frontline and public healthcare settings were crucial in developing virus surveillance programs during the coronavirus disease 2019 (COVID19) pandemic caused by the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-Co [....] » Read More

Speaker at Infection Conferences - Ahmad Syibli Othman
Oral Presentation (In-Person)
Ahmad Syibli Othman, Jenner Institute, United Kingdom

Introduction: Malaria continues to be one of the most significant infectious diseases globally. Its existence in various species complicates the development of an efficient broad-spectrum solution. One species that is gaining increased attention in Southeast Asia is Plasmodium kn [....] » Read More

Speaker at Infectious Diseases Conference - Jodi Cooper
Oral Presentation (In-Person)
Jodi Cooper, Decoy Therapeutics, Inc, United States

Decoy Therapeutics is a biotech company pioneering Designable Multi-Antivirals (D-MAVs™) to redefine how viral disease is treated and understood. By harnessing our proprietary IMP³ACT platform, which integrates AI-enabled design with rapid synthesis, we develop adaptab [....] » Read More

Speaker at Infectious Diseases Conferences - Ranjan Ramasamy
Oral Presentation (In-Person)
Ranjan Ramasamy, ID-FISH Technology, United States

Epstein–Barr virus infection and Human Leukocyte Antigen Class II allele DRB1*1501 increase the risk of developing multiple sclerosis, an autoimmune disease of the central nervous system. Human endogenous retroviral envelope proteins, molecular mimicry and neuroinflammation [....] » Read More

Speaker at Infectious Diseases Conference - Ambreen Sultana
Oral Presentation (Virtual)
Ambreen Sultana, Holy Spirit Hospital, India

Background: In patients with pneumococcal meningoencephalitis, neurological worsening is often reflexively labeled as ischemic stroke or failure of antimicrobial therapy. However, apparent clinical recovery can be deceptive. A hidden immune-mediated phase may emerge after infecti [....] » Read More

Speaker at Infection Conference - Khaled Waleed Salama Hemdan
Oral Presentation (Virtual)
Khaled Waleed Salama Hemdan, October 6th University, Egypt

Background: Human Immunodeficiency Virus (HIV) remains a global health burden despite advances in antiretroviral therapy (ART). Challenges with daily adherence and multidrug resistance (MDR) necessitate novel approaches. Lenacapavir, a long-acting HIV-1 capsid inhibitor admi [....] » Read More

Speaker at Infection Conference - Hariharan S Naidu
Oral Presentation (Virtual)
Hariharan S Naidu, Holy Spirit Hospital, India

Background: In patients with pneumococcal meningoencephalitis, neurological worsening is often reflexively labeled as ischemic stroke or failure of antimicrobial therapy. However, apparent clinical recovery can be deceptive. A hidden immune-mediated phase may emerge after infecti [....] » Read More

Speaker at Infectious Diseases Conference - Muhammad Zakwan Zakariya
Oral Presentation (Virtual)
Muhammad Zakwan Zakariya, Lancashire Teaching Hospitals NHS Foundation Trust, United Kingdom

Background: Orthostatic hypotension is commonly attributed to volume depletion, medication effect, cardiac disease or endocrine dysfunction. However, persistent orthostatic hypotension after correction of reversible causes should prompt consideration of cardiovascular autonomic f [....] » Read More

Speaker at Infectious Diseases Conference - Jin Hur
Poster Presentation (In-Person)
Jin Hur, Jeonbuk National University, Korea, Republic of

The protective efficacy of a novel trivalent inactivated Salmonella bacterial vaccine against Salmonella Infantis infection was evaluated in Hy-Line Brown layers. Forty layers were randomly divided into three groups (A to C), with Group B mock-vaccinated with sterile PBS (IM) and [....] » Read More

Speaker at Infectious Diseases Conference - Mallak Alnaabi
Poster Presentation (In-Person)
Mallak Alnaabi, Resident, Oman

Background: Sickle cell disease (SCD) is a hereditary hemoglobinopathy typically presenting in early childhood. However, individuals with higher fetal hemoglobin (HbF) levels may exhibit a milder phenotype, delaying recognition until adulthood. Co-infections, such as dengu [....] » Read More

Speaker at Infectious Diseases Conference - Sergio Silvestre Soto Sanchez
Poster Presentation (In-Person)
Sergio Silvestre Soto Sanchez, University of Monterrey, Mexico

Pulmonary cryptococcosis in immunocompetent individuals represents an underestimated diagnostic and therapeutic challenge, with growing relevance in clinical practice and global public health. Although historically associated with advanced immunosuppression—particularly HIV [....] » Read More

Speaker at Infectious Diseases Conferences - Darehyne Avila Pina
Poster Presentation (In-Person)
Darehyne Avila Pina, University of Medical Sciences of Cienfuegos, Cuba

Histoplasmosis is a systemic mycosis of worldwide distribution caused by the inhalation of Histoplasma capsulatum spores. It is characterized by wide clinical variability depending on the fungal load, the patient's immunological status and the virulence of the germ. Object [....] » Read More

Speaker at Infectious Diseases Conference - John Luis Wee
Poster Presentation (In-Person)
John Luis Wee, Chong Hua Hospital, Philippines

Introduction: Infected pseudoaneurysms, though rare, are serious complications arising from septic emboli and pose significant diagnostic and management challenges. The common iliac artery is an unusual site for such aneurysms, accounting for only 2-6% of documented cases. This r [....] » Read More

Speaker at Infectious Diseases Conferences - Kate Cassandra Digaum
Poster Presentation (In-Person)
Kate Cassandra Digaum, Chong Hua Hospital Cebu, Philippines

Background: Streptococcus dysgalactiae (SD) is an uncommon human pathogen and its invasive course and clinical outcomes remain unknown. Bacteremia due to SD with systemic complications is rare with an incidence rate of 7/100,000, and survival in such cases is even rarer. Here, we [....] » Read More

Speaker at Infection Conference - Desiree Sor Mejica
Poster Presentation (In-Person)
Desiree Sor Mejica, Vicente Sotto Memorial Medical Center, Philippines

Background: Acinetobacter baumannii is a multidrug-resistant pathogen causing severe ICU-acquired infections with high morbidity and mortality. Identifying local risk factors is essential for targeted infection prevention and control. Objective: To identify clinical and proced [....] » Read More

Speaker at Infectious Diseases Conference - Carlos Yesid Soto Ospina
Poster Presentation (In-Person)
Carlos Yesid Soto Ospina, National University of Colombia, Colombia

Tuberculosis (TB) remains the leading cause of death from a bacterial pathogen worldwide, and the limited efficacy of the century-old Mycobacterium bovis Bacillus Calmette–Guérin (BCG) vaccine underscores the urgent need for novel, rationally designed vaccines capabl [....] » Read More

Speaker at Infection Conferences - Andres Alejandro Rodriguez Bobadilla
Poster Presentation (In-Person)
Andres Alejandro Rodriguez Bobadilla, Universidad Manuela Beltran, Colombia

Background: Tuberculosis is a recognized complication associated with the use of biologic therapies for the treatment of autoimmune diseases. The risk of tuberculosis among treated patients may be further increased in tuberculosis-endemic settings such as Colombia. Objective: [....] » Read More

Speaker at Infectious Diseases Conference - Mila Blatz
Poster Presentation (In-Person)
Mila Blatz, Syracuse University, United States

Objective: To examine the equity and inequity inherent in wastewater surveillance systems under different design specifications, using New York State as a case study. Methods: In addition to evaluating the equity of inclusion, we introduce two novel measures of equity in infec [....] » Read More

Speaker at Infection Conferences - Yuxi Liu
Poster Presentation (In-Person)
Yuxi Liu, Chinese Academy of Medical Sciences & Peking Union Medical College, China

Background: Influenza vaccination is an effective measure for preventing influenza and its complications, yet vaccine uptake among children remains low in many parts of China, particularly in low-resource settings. Evidence on how multilevel school-based intervention strategies c [....] » Read More

Speaker at Infectious Diseases Conference - Sarvin Youssefizad
Poster Presentation (In-Person)
Sarvin Youssefizad, USC Keck School of Medicine, United States

Background : Patients receiving immunosuppressive therapy for B-Cell cancers such as lymphoma and leukemia, may be at an increased risk for reactivation of Hepatitis B infections. Immune Checkpoint Inhibitors,(ICIs), weakens immune responses that control latent viruses. Reactivat [....] » Read More

Speaker at Infectious Diseases Conference - Marios Gerou
Poster Presentation (In-Person)
Marios Gerou, "Evangelismos" General Hospital Athens, Guam

The purpose of this submission is to present a case report of a patient with disseminated nocardiosis and myasthenia gravis. A 69-year-old male patient presented to the Emergency Department of our hospital with a several-day history of right upper leg swelling and tenderness. [....] » Read More

Speaker at Infection Conferences - Priya Vadivel Sreenivasan
Poster Presentation (In-Person)
Priya Vadivel Sreenivasan, All India Institute of Medical Sciences, India

Background: Antimicrobial resistance (AMR) is recognised as one of the top ten global public health threat by World health organisation. Inappropriate and misuse of antibiotics play a major role in the emergence of multidrug resistant organisms which ultimately leads to trea [....] » Read More

Speaker at Infectious Diseases Conference - Jalees A Nasir
Poster Presentation (In-Person)
Jalees A Nasir, McMaster University, Canada

Antibiotic resistance is a complex problem with many interwoven concepts, spanning from individual drug-to-gene interactions to entire gene clusters working in tandem to evade antibiotics. The Comprehensive Antibiotic Resistance Database (CARD) represents individual antimicrobial [....] » Read More

Speaker at Infectious Diseases Conference - Eva Israyelyan
Poster Presentation (In-Person)
Eva Israyelyan, USC Keck School of Medicine, United States

Background : Patients receiving immunosuppressive therapy for B-Cell cancers such as lymphoma and leukemia, may be at an increased risk for reactivation of Hepatitis B infections. Immune Checkpoint Inhibitors,(ICIs), weakens immune responses that control latent viruses. Reactivat [....] » Read More

Speaker at Infectious Diseases Conference - Hannah Bray
Poster Presentation (Virtual)
Hannah Bray, Corewell Health West/Michigan State University, United States

Introduction: Four-valve endocarditis is exceedingly rare, typically bacterial in origin, and associated with high morbidity and mortality. To our knowledge, we report the first case of quadruple-valve endocarditis caused by Candida parapsilosis. Case Presentation: A 38-year-o [....] » Read More

Speaker at Infectious Diseases Conference - Gustavo Gomedi
Poster Presentation (Virtual)
Gustavo Gomedi, São Paulo State University (UNESP), Brazil

Introduction: The complicated parapneumonic pleural effusion (CPPE), or empyema, stands for an important pneumonia’s complication in pediatric population, being associated to higher hospitalization and the need to surgical approach. Current medical literature describes high [....] » Read More

Speaker at Infectious Diseases Conference - Gustavo Gomedi
Poster Presentation (Virtual)
Gustavo Gomedi, São Paulo State University (UNESP), Brazil

Introduction: The complicated parapneumonic pleural effusion (CPPE), or empyema, stands for an important pneumonia’s complication, being associated to higher morbimortality, hospitalization and the frequent need to surgical approach. This article’s goal was to describ [....] » Read More

Speaker at Infectious Diseases Conference - Sergey Suchkov
Keynote Presentation (In-Person)
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation

Personalized and Precision Medicine (PPM).is being the Grand Challenge to forecast, to pre-dict and to prevent is rooted in a big and a new SCIENCE generated by the achievements of (i) Systems & Synthetic Biology; (ii) Bi-odesign-driven Translationa applications and Biotech-d [....] » Read More

Speaker at Infection Conference - Nathalie Silvestre
Keynote Presentation (In-Person)
Nathalie Silvestre, Transgene, France

Monkeypox (mpox) is a zoonotic disease caused by the Monkeypox virus (MPXV). Recent global outbreaks in non-endemic countries demonstrated their significance as a threat to public health. The main approved and widely used vaccine to fight MPXV infection, MVA-BN®, is based on [....] » Read More

Speaker at Infection Conference - Michele Mishto
Keynote Presentation (Virtual)
Michele Mishto, Francis Crick Institute, United Kingdom

MHC class I complexes can present antigenic peptides that derive from canonical proteins as well as have a sequence produced by post-translational mechanisms such as proteasome-generated peptide splicing. Few pathogen-derived proteasome-generated spliced epitopes have been invest [....] » Read More

Speaker at Infection Conferences - Masafumi Seki
Keynote Presentation (Virtual)
Masafumi Seki, Saitama Medical University International Medical Center, Japan

Introduction: We had severe respiratory infection cases after COVID-19 pandemic in Japan. At first, three cases of severe influenza that required ventilator management in the 2024-2025 season, which was a major influenza season in Japan, are presented. Case series: Case 1: [....] » Read More

Speaker at Infectious Diseases Conferences - Xiaoyun Zhao
Keynote Presentation (Virtual)
Xiaoyun Zhao, Tianjin University Chest Hospital, China

Mesenchymal stem cells (MSCs) and their exosomes (MSC-Exo) are promising for treating infection-induced Acute Respiratory Distress Syndrome (ARDS), mainly via paracrine effects involving immunomodulation, anti-inflammation, antimicrobial activity, and tissue repair, rather than d [....] » Read More

Speaker at Infectious Diseases Conferences - Saurabh Chattopadhyay
Keynote Presentation (Virtual)
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States

Interferon regulatory factors (IRFs) are classically viewed as transcription factors that induce interferons and antiviral genes during viral infection. Our work reveals that IRF biology extends beyond transcriptional control to include non-canonical functions that shape host res [....] » Read More

Speaker at Infectious Diseases Conferences - Francis J Castellino
Keynote Presentation (Virtual)
Francis J Castellino, University of Notre Dame, United States

The molecular and cellular communication between the host and pathogen is critical to survival of both organisms after Group A Streptcoccus pyogenes (GAS) infection.  After attachment and invasion of the pathogen, the human host employs its innate immune system to defend aga [....] » Read More

Speaker at Infection Conferences - Maya Polevoi
Oral Presentation (In-Person)
Maya Polevoi, University of Manitoba, Canada

Objective: People living with HIV (PLHIV) have been disproportionately impacted by the burden of sexually transmitted and blood-borne infections. In this study, we examine the prevalence and incidence of eleven sexually transmitted and bloodborne infections (STBBIs) in PLHIVIV in [....] » Read More

Speaker at Infectious Diseases Conference - Sergey Suchkov
Oral Presentation (In-Person)
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation

A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, personalized and precision medicine (PPM). To achieve the im-plementation of PPM concept, it is necessary to create a fundamentally new strategy based upon the subcli [....] » Read More

Speaker at Infectious Diseases Conference - Robson Amaro Augusto da Silva
Oral Presentation (In-Person)
Robson Amaro Augusto da Silva, Federal University of Bahia, Brazil

Antimicrobial Photodynamic Therapy (aPDT) has become a potential alternative for treating multidrug-resistant bacterial skin infections like those caused by methicillin-resistant Staphylococcus aureus (MRSA), who are at high risk in older people. One of the main components of aPD [....] » Read More

Speaker at Infectious Diseases Conferences - Smriti Chaudhary
Oral Presentation (Virtual)
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom

False positive HIV screening results, while uncommon, carry significant clinical and psychological consequences due to the anxiety and diagnostic uncertainty they generate. One recognised but rare cause is acute Epstein-Barr virus (EBV) infection, which may cross-react with fourt [....] » Read More

Speaker at Infection Conferences - Zoya Malik
Oral Presentation (Virtual)
Zoya Malik, The Dudley Group NHS Foundation Trust, United Kingdom

A 24-year-old previously healthy woman presented with a one -week history of severe, sharp right occipital headache (pain score 9-10/10). There were no visual, auditory, or focal neurological symptoms, and no history of trauma or systemic illness. Neurological and systemic examin [....] » Read More

Speaker at Infection Conference - Carmel Couch
Oral Presentation (Virtual)
Carmel Couch, Illawarra Shoalhaven Local Health District, Australia

Traditionally, infection control has focused on direct person-to-person transmission of Carbapenemase-producing enterobacterales (CPE). However, emerging evidence highlights environmental reservoirs - particularly contaminated clinical hand basins (CHBs) - as critical transmissio [....] » Read More

Speaker at Infection Conferences - Lina Awada
Oral Presentation (Virtual)
Lina Awada, Food and Agriculture Organization of the United Nations, Italy

One Health (recognizes the interdependence of human, animal, plant, and environment health, yet its implementation continues to face context-specific challenges. To address these barriers, the One Health Knowledge Nexus was established in 2023 in support of the Quadripartite One [....] » Read More

Speaker at Infectious Diseases Conference - Lucas Ferreira Quintao Moreira
Oral Presentation (Virtual)
Lucas Ferreira Quintao Moreira, Aeronautics Institute of Technology (ITA), Brazil

Dengue remains a major public health challenge in tropical and subtropical regions, with Brazil accounting for over 70% of reported cases in the Americas during the past decade. In recent years, the number of cases has risen sharply, largely driven by the reemergence of DENV-3 ge [....] » Read More

Speaker at Infection Conferences - Yacob Mathai Kunnathazhath
Oral Presentation (Virtual)
Yacob Mathai Kunnathazhath, Marma Health Centre, India

No medical textbook tells us what the purpose of fever is. Without knowing this, no one in the world can define, test, or treat fever. The current definition, testing, and treatment of fever, which is constructed without knowing what the purpose of fever is, has no scientific bas [....] » Read More

Speaker at Infectious Diseases Conferences - Kunalsen Jagatdeo
Oral Presentation (Virtual)
Kunalsen Jagatdeo, Kalinga Institute of Medical Sciences, India

Background: Candida species are the commonest opportunistic fungal infections worldwide. In critically ill patients they may lead to fatal systemic infections. Candidemia is a fatal fungal infection with mortality ranging from 35% to 75%. Of all blood stream infections (BSI), y [....] » Read More

Speaker at Infection Conference - Swati Kumari
Oral Presentation (Virtual)
Swati Kumari, Sri Ramachandra Medical College, India

Acute febrile illnesses in tropical countries are commonly attributed to dengue infection; however, other viral pathogens such as Human Parvovirus B19 (B19V) may present with similar clinical and hematological manifestations, leading to diagnostic challenges and possible misclass [....] » Read More

Speaker at Infectious Diseases Conferences - Percival C Dilla
Oral Presentation (Virtual)
Percival C Dilla, Region II Trauma and Medical Center, Philippines

Background: Streptococcus acidominimus is mainly recognized as a veterinary pathogen; however, it can lead to severe infections in humans, especially in those with pre-existing health issues. Proper identification and timely treatment are essential for effectively managing these [....] » Read More

Speaker at Infectious Diseases Conferences - Percival C Dilla
Oral Presentation (Virtual)
Percival C Dilla, Region II Trauma and Medical Center, Philippines

Background: The COVID-19 pandemic has had a significant impact on the world leading to significant morbidity and mortality. The disease was caused by the SARS-CoV-2 virus and can caused severe respiratory illness, as well as a range of other complications depending on presence of [....] » Read More

Speaker at Infectious Diseases Conferences - Lotgarda Tayao
Oral Presentation (Virtual)
Lotgarda Tayao, San Lazaro Hospital, Philippines

Background: Conventional microbiologic culture has long been the gold standard in microbiological diagnostics, providing valuable information on pathogen viability and antimicrobial susceptibility. However, multiplex polymerase chain reaction (mPCR) has emerged as a powerful alte [....] » Read More

Speaker at Infectious Diseases Conference - Naylya Djumaeva
Oral Presentation (Virtual)
Naylya Djumaeva, Research Institute of Virology, Uzbekistan

Background: Long COVID is characterized by persistent multisystem disturbances following SARS-CoV-2 infection. Beyond organ-specific injury, emerging observations suggest that central neuro-immune–lymphatic pathways may play a key role in the evolution of post-viral dysregu [....] » Read More

Speaker at Infectious Diseases Conference - Naylya Djumaeva
Oral Presentation (Virtual)
Naylya Djumaeva, Research Institute of Virology, Uzbekistan

Background: Long COVID is associated with persistent multisystem symptoms following SARS-CoV-2 infection, yet objective tools to assess ongoing regulatory dysfunction remain limited. Previous research has explored electroacupuncture-according-to-Voll (EAV) diagnostics and me [....] » Read More

Speaker at Infection Conferences - George Riding
Oral Presentation (Virtual)
George Riding, Royal Free Hospital, United Kingdom

Case: A man in his 60s presented with a 7-day history of progressive left periorbital oedema and pruritic vesicular following ipsilateral platelet-rich plasma (PRP) injections for androgenetic alopecia (AA). Pain and swelling started on the day of injection. His past medical [....] » Read More

Speaker at Infectious Diseases Conference - Zeynep Burcin Yilmaz
Oral Presentation (Virtual)
Zeynep Burcin Yilmaz, Inonu University, Turkey

Cytomegalovirus (CMV) infection remains a leading cause of illness and death after liver transplantation (LT). According to current international guidelines, the two most effective strategies to prevent post-transplant CMV infection are antiviral prophylaxis and pre-emptive thera [....] » Read More

Speaker at Infectious Diseases Conferences - Narjis Amar
Oral Presentation (Virtual)
Narjis Amar, Université Libre de Bruxelles, Belgium

Group B Streptococcus (GBS) frequently colonizes the maternal genital tract and can be a significant cause of severe maternal and neonatal infections. However, there is limited knowledge about the maternal immune and inflammatory responses to GBS colonization and transmission, es [....] » Read More

Speaker at Infection Conference - Beatricia Alyssandra Lat Luceno
Oral Presentation (Virtual)
Beatricia Alyssandra Lat Luceno, Philippine General Hospital, Philippines

Introduction: Managing patients admitted to the PICU involves early detection and treatment of shock and hemodynamic stability. Various vascular and extravascular elements must constantly interact to maintain hemodynamic stability. These have been the basis of pediatric age-adjus [....] » Read More

Speaker at Infection Conferences - Jenna Shoman
Oral Presentation (Virtual)
Jenna Shoman, Harvard University, United States

Background: Emerging artemisinin resistance and escalating insecticide resistance threaten recent gains in malaria control across sub-Saharan Africa. Despite this growing heterogeneity in parasite genetics and transmission intensity, intervention strategies are frequently deploye [....] » Read More

Speaker at Infectious Diseases Conference - Mariyah Yousuf
Oral Presentation (Virtual)
Mariyah Yousuf, Sharda University, India

Introduction: Sepsis is a life-threatening condition caused by a dysregulated host response to infection resulting in organ dysfunction. Early diagnosis and risk stratification are crucial to reduce morbidity and mortality. Procalcitonin (PCT), a biomarker of bacterial infection, [....] » Read More

Speaker at Infectious Diseases Conference - Su Latt Paing
Oral Presentation (Virtual)
Su Latt Paing, Torbay Hospital, United Kingdom

Lemierre's syndrome, thrombophlebitis of the Internal Jugular Vein (IJV) with secondary sepsis and infective metastatic lesions, is a rare complication typically of anaerobic bacterial infection of the oropharynx, occurring predominately in the younger adult population. About [....] » Read More

Speaker at Infectious Diseases Conference - Yongfeng Yang
Oral Presentation (Virtual)
Yongfeng Yang, Chinese PLA General Hospital, China

Background: Ultrasonography is the most widely used technique to diagnose echinococcosis; however, challenges in using this technique and the demand on medical resources, especially in low-income or remote areas, can delay diagnosis. We aimed to develop a deep convolutional neura [....] » Read More

Speaker at Infectious Diseases Conferences - Navanitha Chandrasekaran
Oral Presentation (Virtual)
Navanitha Chandrasekaran, Universiti Kebangsaan Malaysia, Malaysia

Background: AmpC β-lactamase hyperproducing Enterobacterales (ABLHE) are significant causes of bloodstream infections, often associated with multidrug resistance and high mortality. This study aimed to determine the 30-day all-cause mortality rate and its risk factors, to de [....] » Read More

Speaker at Infectious Diseases Conference - Barsha Saha
Oral Presentation (Virtual)
Barsha Saha, University of Missouri-Kansas City, United States

Compartmental models are essential for studying host–pathogen dynamics, evaluating intervention effectiveness, and predicting infection trends. However, the utility of these models for testing competing hypotheses is often overlooked. To address this, we propose a new model [....] » Read More

Speaker at Infection Conferences - Jun Zou
Oral Presentation (Virtual)
Jun Zou, Georgia State University Institute for Biomedical Science, United States

Respiratory viral infections, including influenza, remain a major global health concern and disproportionately affect individuals with diabetes, who are at increased risk of severe disease and complications. This heightened susceptibility has traditionally been attributed to the [....] » Read More

Speaker at Infectious Diseases Conference - Adam Bowden
Oral Presentation (Virtual)
Adam Bowden, York and Scarborough Teaching Hospitals NHS Foundation Trust, United Kingdom

Background: Streptococcus salivarius is a viridans group streptococcus that forms part of the normal oral flora and is a rare cause of infective endocarditis (IE). Cases are typically associated with poor dentition, dental procedures, or underlying structural cardiac disease. Spl [....] » Read More

Speaker at Infectious Diseases Conference - Maria Alejandra Vethencourt Ysea
Oral Presentation (Virtual)
Maria Alejandra Vethencourt Ysea, Latin University of Costa Rica, Costa Rica

Zoonotic parasites present in dogs and cats, such as Toxocara canis and Toxocara cati, pose a risk, especially in recreational areas where people live with their pets. These helminths are responsible for visceral larva migrans syndrome. The objective of this study was t [....] » Read More

Speaker at Infectious Diseases Conference - Zeynep Burcin Yilmaz
Oral Presentation (Virtual)
Zeynep Burcin Yilmaz, Inonu University, Turkey

Chronic Hepatitis B (CHB) is a significant public health problem affecting approximately 254 million people worldwide and causing 1.1 million deaths annually. Currently, functional cure — defined as HBsAg loss — is achieved at limited rates with existing antiviral tre [....] » Read More

Speaker at Infection Conferences - Urooj Khalida Saeed
Oral Presentation (Virtual)
Urooj Khalida Saeed, Russell’s Hall Hospital, United Kingdom

A 24-year-old previously healthy woman presented with a one -week history of severe, sharp right occipital headache (pain score 9-10/10). There were no visual, auditory, or focal neurological symptoms, and no history of trauma or systemic illness. Neurological and systemic examin [....] » Read More

Speaker at Infectious Diseases Conference - Zara Small
Poster Presentation (In-Person)
Zara Small, Hampshire Hospitals NHS Foundation Trust, United Kingdom

Background: This audit assesses the coverage of first and second line antibiotic regimens for community and hospital acquired sepsis of unknown origin using blood culture isolates at Hampshire Hospitals NHS Foundation Trust. Coverage was compared across two periods: June and July [....] » Read More

Speaker at Infectious Diseases Conferences - Yolanda Prado
Poster Presentation (In-Person)
Yolanda Prado, Universidad Andres Bello, Chile

Background: Post-sepsis syndrome (PSS) affects up to 50% of survivors, with a mortality exceeding 82% at 5 years and annual costs exceeding $100 billion only in the United States. While immune dysregulation has dominated PSS research, coagulopathy emerges as a silent but critical [....] » Read More

Speaker at Infectious Diseases Conference - Sushmita Das
Poster Presentation (In-Person)
Sushmita Das, Armed Forces Medical College, India

Background: Ventriculoperitoneal (VP) shunts are a well-established treatment for hydrocephalus; however, distal shunt complications such as peritoneal cerebrospinal fluid (CSF) pseudocysts are uncommon and may present with misleading extracranial features. In tuberculosis (TB)&n [....] » Read More

Speaker at Infectious Diseases Conference - Priyanka Shekhawat
Poster Presentation (Virtual)
Priyanka Shekhawat, Mass General Brigham, United States

Background: Opportunistic central nervous system (CNS) infections are uncommon but devastating complications of solid organ transplantation (SOT). Although individual pathogens are relatively rare, CNS infections collectively account for up to 10% of transplant-associated complic [....] » Read More

Speaker at Infectious Diseases Conference - Rico Leonardo Lizbinski
Poster Presentation (Virtual)
Rico Leonardo Lizbinski, Northern Light Health, United States

Objective: To present a 72-year-old gentleman with severe Babesiosis and Lyme disease co-infection complicated by multisystem organ failure. Background:Babesiosis is a rare parasitic disease transmitted by ticks that affects red blood cells and can cause serious illness i [....] » Read More

Speaker at Infection Conferences - Hana Raza
Poster Presentation (Virtual)
Hana Raza, Mclaren Oakland Hospital, United States

Disseminated Herpes Zoster (DHZ) is typically seen in immunocompromised patients and is rare in immunocompetent individuals, posing a significant diagnostic challenge when it presents atypically. We report a case of a 47-year-old immunocompetent female with no identifiable risk f [....] » Read More

Speaker at Infectious Diseases Conference - Christos Simoglou
Poster Presentation (Virtual)
Christos Simoglou, General Hospital of Xanthi, Greece

Objective: Endocarditis is a severe, potentially fatal infection of cardiac valves or endocardium, characterized by high morbidity and complex management. This study aims to synthesize contemporary clinical, microbiological, and therapeutic data, highlighting strategies for early [....] » Read More

Speaker at Infectious Diseases Conference - Christos Simoglou
Poster Presentation (Virtual)
Christos Simoglou, General Hospital of Xanthi, Greece

Background: Suppurative hidradenitis of the breast is an uncommon and diagnostically challenging condition that frequently mimics infectious mastitis or inflammatory breast carcinoma. Its atypical and recurrent nature often leads to extensive diagnostic workups and unnecessary in [....] » Read More

Speaker at Infectious Diseases Conference - Idessania Nazareth Costa
Poster Presentation (Virtual)
Idessania Nazareth Costa, Independent Researcher, Brazil

Introduction: Toxoplasmosis, an infection caused by the protozoan Toxoplasma gondii, becomes serious in immunocompromised individuals, ocular toxoplasmosis, and, especially, in cases of congenital infection. Treatment of toxoplasmosis is hampered by the toxicity of conventional m [....] » Read More

Speaker at Infection Conference - Bruna Barros da Fonseca
Poster Presentation (Virtual)
Bruna Barros da Fonseca, University of Western São Paulo UNOESTE, Brazil

This case illustrates a rare and challenging clinical presentation of AIDS with multiple simultaneous opportunistic coinfections, including viral, bacterial, fungal, and parasitic etiologies. We report the case of a 30-year-old male patient admitted to the intensive care unit of [....] » Read More

Speaker at Infection Conference - Bruna Barros da Fonseca
Poster Presentation (Virtual)
Bruna Barros da Fonseca, University of Western São Paulo UNOESTE, Brazil

Takotsubo syndrome, also known as broken heart syndrome, is characterized by transient left ventricular dysfunction. Previous clinical conditions, such as Mycobacterium tuberculosis infection, can act as precipitating factors. It is a rare condition, more common in white women wi [....] » Read More

Speaker at Infectious Diseases Conference - Nilton Gabriel Vicente Fernandes da Silva
Poster Presentation (Virtual)
Nilton Gabriel Vicente Fernandes da Silva, University of Western São Paulo - UNOESTE, Brazil

Male patient, 35 years old, with a personal history of HIV diagnosis one year ago with irregular treatment, and pulmonary tuberculosis infection with complete treatment and discharge due to cure two years ago, resident of a free area, cocaine user, with grade III malnutrition. He [....] » Read More

Speaker at Infectious Diseases Conference - Nilton Gabriel Vicente Fernandes da Silva
Poster Presentation (Virtual)
Nilton Gabriel Vicente Fernandes da Silva, University of Western São Paulo - UNOESTE, Brazil

Community-associated methicillin-resistant Staphylococcus aureus infection is a rare condition, with pneumonia being an uncommon manifestation, especially in previously healthy individuals. A 13-year-old male patient with no previous medical history was admitted to an infectious [....] » Read More

Speaker at Infection Conferences - Bruna dos Santos Costa
Poster Presentation (Virtual)
Bruna dos Santos Costa, University of Western São Paulo - UNOESTE, Brazil

Viral pneumonia caused by the Varicella Zoster virus is a rare but serious complication with a high mortality rate. A 17-year-old male patient, previously healthy, was admitted to an infectious disease hospital with confluent, polymorphic, centripetal papulovesicular rashes that [....] » Read More

Speaker at Infectious Diseases Conferences - Barbara Alves Rhomberg
Poster Presentation (Virtual)
Barbara Alves Rhomberg, University of Western São Paulo - UNOESTE, Brazil

The Hepatitis A virus usually causes a self-limiting disease, with fulminant hepatic failure occurring in less than 1% of cases. A 40-year-old white male patient, self-employed, with a personal history of cholecystectomy 11 months prior, with no other comorbidities or ongoing med [....] » Read More

Speaker at Infectious Diseases Conferences - Barbara Alves Rhomberg
Poster Presentation (Virtual)
Barbara Alves Rhomberg, University of Western São Paulo - UNOESTE, Brazil

Elevated liver enzymes occur in up to 50 to 90% of patients with dengue, usually with a slight elevation and no clinical significance. In severe cases, the elevation can reach up to ten times the normal value, associated with severe liver inflammation and liver failure in about 0 [....] » Read More

Speaker at Infection Conference - Simoiu Madalina
Poster Presentation (Virtual)
Simoiu Madalina, "Carol Davila" University of Medicine and Pharmacy of Bucharest, Romania

Legionella pneumophila is an aerobe, non-sporulated, facultative intracellular, mobile, gram-negative bacillus. It’s the cause of pneumonia in immunosuppressed patients, usually in a severe form which can expand to multiple lobes, or occasionally, a self-limited mild form, [....] » Read More

Speaker at Infection Conferences - Enerik
Poster Presentation (Virtual)
Enerik, University Hospital Center “Mother Teresa”, Albania

Introduction: Ankylosing spondylitis (AS) is a long-term (chronic) disease. The spine, or other areas of the body, become inflamed, causing part of the spinal column to fuse and lose flexibility (ankylosis). AS affects 1 in 200 individuals and is usually diagnosed many years afte [....] » Read More

Speaker at Infection Conferences - Jozen Ray Dragon
Poster Presentation (Virtual)
Jozen Ray Dragon, Vicente Sotto Memorial Medical Center Department of Internal Medicine, Philippines

Introduction: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) significantly contribute to morbidity and mortality worldwide. Understanding the demographic, clinical, microbiological characteristics, and outcomes of AECOPD patients is essential for optim [....] » Read More

Speaker at Infection Conference - Skaiste Zukaitiene
Poster Presentation (Virtual)
Skaiste Zukaitiene, Lithuanian University of Health Sciences, Lithuania

Introduction: A fundamental principle of rational antimicrobial therapy is the ability of a drug to achieve concentrations at or above the minimum inhibitory concentration (MIC) at the site of infection. In central nervous system (CNS) infections, cerebrospinal fluid (CSF) drug c [....] » Read More

Speaker at Infectious Diseases Conference - Safia Chaabi
Poster Presentation (Virtual)
Safia Chaabi, Ibn Rochd University Hospital Center, Morocco

Cocaine body packing, which is the intentional ingestion of drug-containing packets, has been a major risk factor for fatal consequences if a packet ruptures. Of these, peritonitis secondary to gastrointestinal perforation, though uncommon, is a surgical emergency with high morta [....] » Read More

Speaker at Infectious Diseases Conference - Chaimae Chiguer
Poster Presentation (Virtual)
Chaimae Chiguer, Ibn Rochd University Hospital, Morocco

Introduction: Severe traumatic brain injury (TBI) is defined as a high-risk global condition with a Glasgow Coma Scale score ≤ 8 that continues to challenge global public health, particularly among young adults. Despite the recent advances in the critical care arena, mortality [....] » Read More

Speaker at Infection Conference - Mohammed Sayeemuddin
Poster Presentation (Virtual)
Mohammed Sayeemuddin, King's College Hospital NHS trust, United Kingdom

Background: Early onset sepsis is a leading cause of morbidity and mortality in neonates requiring early detection and treatment. However, often it can present with non-specific clinical signs and symptoms. It is therefore important to have an effective screening tool which can b [....] » Read More

Speaker at Infectious Diseases Conference - John Matthew S Tan
Poster Presentation (Virtual)
John Matthew S Tan, West Visayas State University Medical Center, Philippines

Background. Latent tuberculosis infection (LTBI) reflects a sustained immune response to Mycobacterium tuberculosis without active disease. Despite global progress toward the WHO “End TB Strategy,” household contacts of TB patients remain at high risk of infection. Ga [....] » Read More

Speaker at Infectious Diseases Conference - Rebeca Dall Aqua de Godoy
Poster Presentation (Virtual)
Rebeca Dall Aqua de Godoy, Faculty of Medicine of São José do Rio Preto, Brazil

Background: Tuberculosis (TB) infection remains a leading cause of morbidity and mortality worldwide, particularly among people living with HIV/AIDS (PLWHA), in whom coinfection substantially exacerbates disease severity and worsens clinical outcomes. The COVID-19 pandemic prof [....] » Read More

Speaker at Infectious Diseases Conferences - Lyashuk Safiya
Poster Presentation (Virtual)
Lyashuk Safiya, North-Western State Medical University named after I.I. Mechnikov, Russian Federation

Introduction: Mucormycosis is a severe disease with high mortality caused by fungi of the order Mucorales, mainly in immunocompromised patients. Uncontrolled diabetes mellitus is one of the risk factors for the development of the disease. The purpose of this study was to study ba [....] » Read More

Speaker at Infectious Diseases Conference - Panova Yuliya
Poster Presentation (Virtual)
Panova Yuliya, North-Western State Medical University named after I.I. Mechnikov, Russian Federation

Invasive fungal infections are a growing problem in critically ill patients and are associated with increased morbidity and mortality. Most of them are due to Candida and Aspergillus species. Successful treatment of these infections and the use of antifungal prophylaxis [....] » Read More

Speaker at Infectious Diseases Conference - Feryal Hilmi
Poster Presentation (Virtual)
Feryal Hilmi, Philadelphia College of Osteopathic Medicine, United States

We report a 19 year old female who presents for follow up for surgical consultation two years post limb amputation. Two years prior, the patient, then 17 years old, had presented to the emergency department with fever, malaise, and respiratory symptoms, progressing to hypotension [....] » Read More

Speaker at Infection Conferences - Carolyn Cross
Poster Presentation (Virtual)
Carolyn Cross, Ondine Biomedical Inc., Canada

Background: Nasal decolonization is central to SSI prevention, with mupirocin long regarded as the topical “gold standard” for eliminating Staphylococcus aureus carriage. However, real world implementation exposes a Mupirocin Paradox: programmes that successfully redu [....] » Read More

Speaker at Infection Conferences - Carolyn Cross
Poster Presentation (Virtual)
Carolyn Cross, Ondine Biomedical Inc., Canada

Surgical Site Infection (SSI) surveillance in cardiac surgery is distorted by a double whammy: systematic under-reporting of true infection rates and reliance on outdated, non inflation adjusted cost data. Enhanced recovery protocols have shortened inpatient stays, but national r [....] » Read More

Speaker at Infectious Diseases Conference - Chun Hsiang Chiu
Poster Presentation (Virtual)
Chun Hsiang Chiu, National Defense Medical University, Taiwan

Background: The long-term impact of coronavirus (COVID)-19 and the possibility of secondary infections have not yet been defined. Because COVID-19 has become a common community infection, patients are often hospitalised with COVID-19 accompanied by unrelated comorbidities (overlo [....] » Read More

Speaker at Infectious Diseases Conference - Tawakalit Olubukola Salam
Poster Presentation (Virtual)
Tawakalit Olubukola Salam, University of Ibadan, Nigeria

Background: The COVID-19 pandemic has affected health workers as one of the groups most at risk of infection. Although vaccines have been manufactured and documented to be a mainstay in prevention and control, many frontline health workers were averse to vaccination due to report [....] » Read More

Speaker at Infectious Diseases Conference - Xin Yi Ng
Poster Presentation (Virtual)
Xin Yi Ng, Wellington Hospital, New Zealand

Background: Clostridium perfringens is a gram-positive, anaerobic, spore-forming bacillus. C. perfringens infections can cause acute and often fatal haemolytic anaemia, mediated by release of the alpha toxin.  Aims: C.perfringens endometritis is more commonly seen in the [....] » Read More

Speaker at Infection Conference - Em Brenner
Poster Presentation (Virtual)
Em Brenner, University of Strathclyde, United Kingdom

People in prison and prison leavers experience disproportionately poorer health outcomes compared to the general population, including a relatively higher prevalence of blood-borne viruses. This is often reported as due to a higher likelihood of risk factors such as sexual practi [....] » Read More

Speaker at Infectious Diseases Conference - Yurdey Fernanda Herran Murillo
Poster Presentation (Virtual)
Yurdey Fernanda Herran Murillo, Center for Studies in Pediatric Infectology (CEIP), Colombia

The WHO has identified vaccine hesitancy as one of the main threats to global health. Given that immunisation prevents around 4.4 million deaths worldwide each year, vaccination during pregnancy remains a key intervention for reducing the burden of disease in the first months of [....] » Read More

Watsapp